Related Experiment Video

Updated: Jul 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Optimal antithrombotic treatment for percutaneous coronary intervention

R A Kadakia1, J J Ferguson

  • 1Texas Heart Institute, St. Luke's Episcopal Hospital, Baylor College of Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Minerva Cardioangiologica
|March 25, 2005
PubMed

Insights

Optimal antithrombotic therapy for percutaneous coronary interventions (PCI) involves carefully selecting antiplatelet and anticoagulant agents. This review details agents like unfractionated heparin (UFH) and glycoprotein IIb/IIIa antagonists, offering guidance for various risk levels in PCI procedures.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Atherosclerotic vascular disease necessitates percutaneous interventions.
  • Anti-platelet and anti-thrombotic agents are crucial for minimizing procedural complications.
  • Optimal antithrombotic therapy in percutaneous coronary interventions (PCI) requires careful consideration of various agents.

Purpose of the Study:

  • To provide a current overview of optimal adjunctive antithrombotic therapy for PCI.
  • To discuss anticoagulant agents (unfractionated heparin, low-molecular weight heparins, direct thrombin inhibitors) and antiplatelet agents (aspirin, thienopyridines, glycoprotein IIb/IIIa antagonists).
  • To offer evidence-based recommendations for procedural anticoagulation based on patient risk stratification.

Main Methods:

  • Review of current literature on antithrombotic agents used in PCI.
  • Discussion of the coagulation process and mechanisms of action of key pharmacological agents.
  • Analysis of clinical trial evidence for anticoagulant and antiplatelet therapies in PCI.

Main Results:

  • Detailed presentation of anticoagulant and antiplatelet agents used adjunctively in PCI.
  • Summary of evidence from recent clinical trials.
  • Recommendations for procedural anticoagulation stratified by patient risk (low, not-low, and high risk).

Conclusions:

  • Individualized decision-making by interventional cardiologists is paramount for determining optimal antithrombotic therapy.
  • Appropriate dosing recommendations for employed agents are provided.
  • The review aims to guide clinicians in selecting the most effective antithrombotic strategies for PCI.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...